# Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria

> **NCT00557518** · PHASE2 · TERMINATED · sponsor: **Synvista Therapeutics, Inc** · enrollment: 80 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetic Nephropathy

## Interventions

- **DRUG:** Alagebrium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00557518
- **Lead sponsor:** Synvista Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-11
- **Primary completion:** 2009-09
- **Final completion:** 2009-11
- **Target enrollment:** 80 (ESTIMATED)
- **Why stopped:** Study has been terminated early due to financial constraints.
- **Last updated:** 2009-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557518, "Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00557518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*